Cognetivity Neurosciences and InterSystems Partner to Fast-track Integration of Early Dementia Detection with Global Healthcare Systems
Partnership with the world-leading technology provider InterSystems supports seamless integration with electronic health records and other care systems to facilitate the adoption of Cognetivity’s early dementia detection platform. Vancouver, BC – May 4, 2021 – Cognetivity Neurosciences Ltd. (OTCQB: CGNSF) (CSE: CGN) (the “Company” or “Cognetivity”) (FWB: 1UB) today announced that it has established […]
Cognetivity Neurosciences Announces Commercial Deployment of OptiMind Wellness App with Market-leading Telehealth Company
Cognetivity’s unique cognition-monitoring technology to be deployed to measure positive impact of employee wellness initiatives, enabling direct feedback and program optimization Vancouver, BC – March 2nd, 2021 – Cognetivity Neurosciences Ltd. (CSE: CGN) (OTCQB: CGNSF) (FWB: 1UB) (the “Company” or “Cognetivity”) today announced that it has reached an agreement with Dutch telehealth company Luscii […]
Cognetivity Neurosciences expands ongoing UK government-funded study to include Covid-safe remote cognitive assessment
Cognetivity’s iPad-based Integrated Cognitive Assessment (ICA) well suited to remote use as global demand for telehealth continues to surge Vancouver, BC – January 12, 2020 – Cognetivity Neurosciences Ltd. (CSE: CGN) (OTCQB: CGNSF) (FWB: 1UB) (the “Company” or “Cognetivity”) today announced the expansion of its UK government-funded study on the use of its Integrated […]
Cognetivity Neurosciences Advances to TMCx Full Accelerator Program to Fast Track US Commercial Development
Cognetivity one of only seven health tech innovators selected to advance to full accelerator program Cohorts receive increased resources and network support to accelerate US market penetration Vancouver, BC – December 23, 2020 – Cognetivity Neurosciences Ltd. (CSE: CGN) (OTCQB: CGNSF) (FWB: 1UB) (the “Company” or “Cognetivity”) today announced that it has been selected […]
Cognetivity Neurosciences to partner with Oxford University in study of smartphone-based remote cognitive assessment
Research will utilise Cognetivity’s Integrated Cognitive Assessment (ICA) technology to study potential early-stage cognitive decline in individuals at risk of developing dementia Vancouver, BC – Decemeber 1, 2020 – Cognetivity Neurosciences Ltd. (the “Company” or “Cognetivity”) (CSE: CGN) (FWB: 1UB) (OTCQB: CGNSF) today announced that it will be collaborating with researchers at Oxford University to […]
